CD274 and glioblastoma: Though the clinical data in this study was limited to a subset of patients with wild-type IDH-1 glioblastoma under α-PD-L1 treatment, the concurrent dexamethasone diminished the response to α-PD-1 therapy in two different mouse glioma models[145].